⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VNRX News
VolitionRX Limited Common Stock
Form 8-K
sec.gov
VNRX
VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France
prnewswire.com
VNRX
VolitionRx Participates in Launch of DETECSEPS Program in France
prnewswire.com
VNRX
Form 8-K
sec.gov
VNRX
Form 8-K
sec.gov
VNRX
VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027
prnewswire.com
VNRX
Volition Presents Early Stage I Solid Cancer Detection at the ESMO MAP Conference
prnewswire.com
VNRX
Form 8-K
sec.gov
VNRX
Form 8-K
sec.gov
VNRX
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets
prnewswire.com
VNRX